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Abstract
Background: Effective diagnosis of Johne’s disease (JD), particularly at the stage of early subclinical infection,
remains one of the greatest challenges for the control of JD worldwide. The IFN-g test of cell mediated immunity
is currently one of the most suitable diagnostics for subclinical infections, however a major limitation of this test is
the lack of a standardised purified protein derivative (PPD) antigen (also referred to as Johnin PPD or PPDj). While
attempting to replace PPDj with more specific individual antigens is an attractive proposition, bacterial culture
derived PPDj remains the most effective antigen preparation for the diagnosis of subclinical JD. It may be possible
to increase the reproducibility and specificity of PPDj preparations by further characterising and standardising the
PPDj production.
Results: Using a standardised protocol, five in-house preparations of PPDj were prepared from cultures of
Mycobacterium avium subsp. paratuberculosis (MAP). Compared to PPDs obtained from other institutes/laboratories,
these preparations appeared to perform similarly well in the IFN-g test. Although the broad proteomic composition
of all PPDj preparations was remarkably similar, the absolute abundance of individual proteins varied markedly
between preparations. All PPDj preparations contained common immunogenic proteins which were also observed
in PPD preparations from Mycobacterium avium subsp. avium (PPDa) and Mycobacterium bovis (PPDb). Temporal
difference in protein secretion of in vitro cultured MAP was observed between 20 and 34 weeks suggesting that
the age of MAP culture used for PPDj preparations may markedly influence PPDj composition.
Conclusions: This study describes a protocol for the production of PPDj and its subsequent proteomic
characterisation. The broad proteomic composition of different preparations of PPDj was, for the most part, highly
similar. Compositional differences between PPDj preparations were found to be a direct reflection of genetic
differences between the MAP strain types used to produce these preparations and the age of MAP cultures they
were derived from. A number of conserved immunogenic proteins, such as members of the cutinase-like protein
family, were found to be more abundant in PPDj compared to PPDa and should be considered as possible
diagnostic antigens for the future.
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Background
Johne’s disease (JD) is a significant animal health issue
worldwide. JD is a chronic infectious enteritis of wild
and domestic ruminants. Caused by the Gram positive,
acid fast bacilli, Mycobacterium avium subsp.
paratuberculosis (MAP), JD is responsible for significant
financial losses to many livestock industries, most nota-
bly dairy and beef cattle production [1]. Asymptomatic
subclinically infected animals pose a significant chal-
lenge for the control and management of JD. From the
early stages of infection animals have the ability to
excrete large quantities of viable bacilli into the environ-
ment which can subsequently reinfect other members of
the herd. The accurate diagnosis and eradication of
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trol and management of JD worldwide. Although not
proven, MAP may also act as a zoonotic agent in some
human diseases [2-4].
A range of diagnostic tests, varying in their sensitivity,
specificity and suitability have been trialled for the diag-
nosis of MAP infections [5-9]. Serological-based tests
such as ELISA [9], gel immuno-diffusion [7,10] and
complement fixation [5] tests have proven successful for
the diagnosis of the clinical stages of disease when a
robust antibody response has developed. Serological-
based tests, however, have failed to diagnose both early
and subclinical stages of infection. Traditionally, the
early and subclinical stages of infection were thought to
be dominated by cell-mediated immunity (CMI) rather
than circulating antibodies [11]. Recent evidence how-
ever suggests that JD infected sheep are more likely to
have a combined CMI and antibody response during the
early stages of infection [12]. The CMI response against
MAP is characterised by a Th1-type cellular response
leading to the secretion of a number of cytokines,
including interferon gamma (IFN-g) [11].
Diagnostic tests based on measuring CMI response
have proven to be more suitable for the detection of
subclinical stages of infection compared to serological-
b a s e dt e s t s[ 5 ] .T h em o s tc o m m o nt e s to fC M If o rJ D
diagnosis relies on the quantification of released IFN-g
following antigenic stimulation of peripheral blood lym-
phocytes. Originally developed for the diagnosis of
bovine tuberculosis (BOVIGAM™) [13], this IFN-g test
has also been adapted for the diagnosis of subclinical
MAP infections across a range of species including cat-
tle [14,15], sheep [5] and goats [8]. This test is based on
an ELISA and relies on the use of purified protein deri-
vative (PPD) as the stimulating antigen. Johnin PPD
(PPDj) is a crude preparation of MAP culture inacti-
vated by heat treatment, precipitated with trichloroacetic
acid (TCA) and resuspended in phosphate buffer con-
taining glucose and phenol.
While described in the Australia and New Zealand
Standard Diagnostic Procedure (ANZSDP; http://www.
scahls.org.au) for JD diagnosis, the IFN-g test is not rou-
tinely used in Australia due to its low specificity to diag-
nose JD over non-MAP mycobacterial exposure. Indeed,
several studies have demonstrated JD infected animals
cross react with PPD antigen preparations from Myco-
bacterium bovis (PPDb) and Mycobacterium avium
(PPDa) [6,15]. Such cross reactivity is most likely due to
the presence of common immunogenic proteins con-
served across the Mycobacterium genus. Many of these
proteins are major components of PPDb and PPDa
[16,17]. Increasing specificity through, either the repla-
cement of PPDj with individual antigens, or refining
PPD composition, may greatly improve this diagnostic.
PPDj may be refined by simply standardising its produc-
tion, including using a common MAP reference strain,
an optimised harvest time point and production
procedure.
Another major drawback of the IFN-g test, which con-
tributes to its low specificity, concerns the lack of stan-
dardised PPDj preparations. While PPDj is now
produced by a number of different institutes/labora-
tories, its potency to induce an IFN-g response differs
significantly between preparations [7,10,18]. Conse-
quently the concentration of PPDj antigen used in IFN-g
tests varies considerably between laboratories [15].
Globally, a range of genetically diverse MAP strains
have been employed to prepare PPDj [19]. In Canada
alone as many as six different MAP strains have been
used, some of which have been cultured within the
laboratory for many generations [19]. The different
MAP strains used to prepare PPDj may significantly
contribute to the variability between PPDj preparations.
Indeed, strain differences have been shown to signifi-
cantly alter protein expression profiles. A comparison
between the laboratory-adapted reference isolate K10
with a wild type bovine isolate 187 demonstrated the
latter has increased expression of a number of proteins
compared to K10 [20]. Different MAP strains also
demonstrate variation in growth dynamics which may
significantly affect the composition of PPDj depending
on the harvest time point [21].
The variable non-standardised nature of PPDj makes
comparisons between different laboratories difficult.
While attempts to replace PPDj with individual antigens
have proven encouraging [22], PPDj remains the most
widely used diagnostic antigen for subclinical JD diagno-
sis using the IFN-g assay. We believe that by careful
standardisation and characterisation of PPDj it may be
possible to improve this diagnostic antigen and also, in
the process, identify new antigen targets. To this end,
our laboratory has produced PPDj in-house over the
past decade following a standardised laboratory protocol.
These PPDj preparations have been utilised in a number
of published studies and have performed as well as
other available PPDj preparations in their ability to diag-
nose MAP infections [23-25].
I nt h i ss t u d yw ed e s c r i b eas t a n d a r d i s e dp r o t o c o lf o r
the production of PPDj within our laboratory. The pro-
teomic composition of these preparations were then
characterised by mass spectrometry and compared to a
selection of PPD preparations sourced from other insti-
tutes/laboratories. Temporal changes in protein secre-
tion of in vitro cultured MAP were also investigated in
an attempt to identify the optimal harvest time point for
PPDj preparation. Throughout this process a number of
potential antigens were identified and these may serve
as possible diagnostic markers for JD infection. Such
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the future.
Results and Discussion
The ability of the in-house produced AAHL1101 PPDj
to generate an IFN-g response was demonstrated across
13 Holstein-Friesian cattle and 13 Merino sheep experi-
mentally infected with MAP (Figure 1A and 1B). The
IFN-g response of infected cattle against AAHL1101
PPDj was not significantly different compared to the
CSL or CAN6 PPDj preparations (p > 0.05). Interest-
ingly, the IFN-g response of infected sheep against
AAHL1101 PPDj was significantly greater compared to
the CAN6 PPDj preparation (p < 0.05), but not the CSL
preparation (p > 0.05). Infected cattle also responded
against PPDa. In one instance this response was greater
than against PPDj. This result highlights the cross-reac-
tivity inherent with PPDa and PPDj.
A proteomic comparison by mass spectrometry of all
PPD preparations demonstrated significant overlap in
composition between preparations (Figure 2). A total of
269 proteins were identified by TripleTOF™ mass spec-
trometry across all 13 PPDj (Additional file 1: Table S1).
The largest number of proteins (134) was identified in
the AAHL1101 PPDj sample. The NVSL PPDj sample
contained only six detectable proteins. Such a low pro-
tein composition seems unlikely given the complexity of
other PPDj preparations. Mass spectrometry was
repeated on the NVSL PPDjs a m p l eu s i n gL C - M A L D I
and a similar number of proteins were identified (data
not shown). It was concluded that this PPDj sample has
undergone degradation since initial preparation and it
was therefore excluded from further analysis. All other
PPDj samples contained a similar number of proteins
(range 76-134). The majority of these proteins were
shared between one or more PPDj preparations (Figure
2). It is interesting to note that while all PPDj prepara-
tions contained a small number of unique proteins, the
overall composition was conserved across the 12 PPDj
samples. Twenty nine proteins were found to be com-
mon to all PPDj samples (Table 1). These included
many known immunogenic antigens, such as the heat
shock proteins GroES, GroEL and DnaK.T h ef i v e
AAHL PPDj preparations shared 42 common proteins
(Figure 3). The AAHL1101 contained considerably more
unique proteins (59) compared to the other four AAHL
preparations (Figure 3). Considering that the five AAHL
PPDj preparations were produced identically it is sur-
prising that the AAHL1101 preparation contained so
many more unique proteins. This finding suggests that
despite using a standardised strain and production pro-
tocol inherent variation between PPDj preparations will
still exist, albeit to a lesser extent than if no standardisa-
tion was undertaken.


Figure 1 Results of IFN-g assay in Holstein-Friesian cattle (A)
and Merino sheep (B). Control, denotes control (non-MAP
infected) animals. ‘Bacto’, denotes those animals infected with in
vitro cultured MAP. ‘Tissue’, denotes animals infected via
consumption of a tissue biopsy from a JD positive donor. The
individual animal number is also indicated following the group
description.
Figure 2 The number of proteins identified by LC-MS/MS
within each PPD. Proteins identified in two or more PPD samples
are denoted by light grey bars and proteins indentified as unique to
individual PPD preparations are denoted by dark grey bars.
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some extent, to the different MAP strain type used to
produce PPDj globally. Significant genomic differences,
including a 7.9 kb deletion, have been observed in cer-
tain MAP strains used to prepare PPDj [19]. Further-
more single PPDj preparations maybe produced from
combining a number of bacterial cultures of different
strains, thus increasing the inherent variability. In our
laboratory a single wild-type bovine isolate (CLIJ623
[23]) was used to produce PPDj. We have recently
found that this Australian MAP isolate has distinct
genetic differences compared with the US reference iso-
late K10 [4,26]. Many of these genetic polymorphisms
translated into protein variation which may be reflected
in differences in PPDj composition. The absence of the
acyl-CoA dehydrogenase FadE3_2 (MAPK_0117) from
the AAHL PPDj preparations is a perfect example of
genetic strain differences affecting proteomic composi-
tion of PPDj. Multiple reaction monitoring (MRM) ana-
lysis was used to qualify the relative abundance of
FadE3_2 across different PPDj and PPDa samples. Based
on a single C-terminal peptide, MRM demonstrated a
complete absence of this peptide in all AAHL PPD pre-
parations (Figure 4C). Our previous genome sequencing
studies have shown that this gene is truncated by 149
amino acids in the CLIJ623 genome [4]. This truncation
was a consequence of a single base frame shift deletion
which was also observed in MAP isolates derived from
humans. Conversely, K10, and other bovine MAP strains
sequenced in our laboratory, appeared to retain an
intact copy of this gene. It’s also possible that the trun-
cated form of this protein is still expressed in the MAP
strains which contain this SNP. However additional
experimentation would be required to confirm this.
Table 1 Most common proteins observed in 12 PPDj samples
Accession Locus_tag
‡ Locus_tag
¥
Gene Mass (Da) Product PPDb PPDa 20 W sec 34 W sec
P60533 MAPK_4266 MAP_4264 groES 10716.1 10 kDa chaperonin + + + +
Q73YF9 MAPK_1771 MAP_1997 acpM 12452.9 acyl carrier protein + + + +
Q8VU82 MAPK_2159 MAP_1609c fbpB 34692.8 fibronectin-binding antigen 85 complex B + + + +
Q00488 MAPK_3842 MAP_3840 dnaK 66518.5 molecular chaperone DnaK + + + +
Q50320 MAPK_0241 MAP_3527 pepA 35709.1 serine protease + + + +
Q73UE0 MAPK_0340 MAP_3428c 23791.0 cutinase-related + + +
Q73WQ3 MAPK_1161 MAP_2607c fdxC 11792.1 ferredoxin + + + +
Q8GF25 MAPK_2115 MAP_1653 tpx 16684.8 thiol peroxidase + + +
Q73YR6 MAPK_1879 MAP_1889c wag31 28049.9 secreted antigen Wag31 + + +
Q73ZR1 MAPK_2228 MAP_1540 cfp17 16715.2 forkhead-domain protein + + +
Q741F3 MAPK_2630 MAP_1138c lprG 24720.8 lipoprotein + +
P42384 MAPK_3938 MAP_3936 groL2 56642.6 chaperonin GroEL2 + + + +
Q741G8 MAPK_2646 MAP_1122 mIHF 12176.2 integration host factor MihF + + + +
A0QME6 MAPK_0122 MAP_3646 pckA 67659.5 phosphoenolpyruvate carboxykinase (GTP) +
P60545 MAPK_4267 MAP_4265 groL1 55793.3 chaperonin GroEL + +
P61976 MAPK_1227 MAP_2541c mdh 34599.2 malate dehydrogenase + +
Q73TQ9 MAPK_0109 MAP_3659 53750.8 long-chain-fatty-acid–CoA ligase +
Q73VF3 MAPK_0707 MAP_3061c fixA 27847.4 electron transfer flavoprotein (beta-subunit) + + +
Q73VF4 MAPK_0708 MAP_3060c fixB 32085.4 electron transfer flavoprotein (alpha-subunit) + +
Q73X57 MAPK_1315 MAP_2453c atpA 59992.9 H(+)-transporting two-sector ATPase, alpha
subunit
+
P61336 MAPK_0813 MAP_2955c tsf 29065.9 elongation factor Tsf + + +
Q73XM7 MAPK_1486 MAP_2282c tig 50618.2 trigger factor
Q741U7 MAPK_2778 MAP_0990 eno 44841.2 phosphopyruvate hydratase
A0QLN4 MAPK_3950 MAP_3948c 17094.2 hypothetical protein + + +
D5PC72 MAPK_4128 MAP_4126 rplL 13430.4 ribosomal protein L7/L12 + + + +
Q73SD1 MAPK_4145 MAP_4143 tuf 43738.7 protein-synthesizing GTPase + + + +
Q73ZL3 MAPK_2179 MAP_1589c ahpC 21641.4 peroxiredoxin subunit C + +
A0QCX8 MAPK_1317 MAP_2451c atpD 53141.2 H(+)-transporting two-sector ATPase, beta subunit
Q73S77 MAPK_4201 MAP_4199 adk 19935.7 adenylate kinase + + +
The accession number for the protein with highest sequence coverage is given. Locus tag from the revised K10 genome sequence
‡ and original K10 genome
sequence
¥, gene name, mass (Da) and protein name for the MAP K10 ortholog is provided. Proteins also identified in PPDb, PPDa, 20 week or 34 week culture
filtrate are indicated by +
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of strain differences on PPDj composition and highlights
the need for a well characterised reference strain for all
PPDj production globally. Ideally such a reference strain
would contain as many antigenic open reading frames
as possible.
One of the most common families of proteins identi-
fied across all PPDj preparations was the cutinase-like
proteins (CLPs). Cutinases are serine hydrolases which
cleave carboxylic ester bonds of glycolipid polymers
thus producing the cutin monomer. The immunogeni-
city of cutinase enzymes have been demonstrated pre-
viously [27]. M. tuberculosis contains seven CLPs [27]
and four of these were found in tuberculin PPD [16].
We identified seven different CLPs in PPDj (Additional
file 1: Table S1) with the most common CLPs arising
from locus tags MAPK_0273, MAPK_0340, MAPK_1748
and MAPK_2088. MRM quantification of single peptides
corresponding to these CLPs revealed significant differ-
ences in the absolute abundance between PPDj and
PPDa preparations (Figure 4E-3H). This finding suggests
that, while the protein composition of different PPDj
preparations is similar in terms of presence or absence
of proteins, the abundance of individual components
varies significantly. Both MAPK_1748 and MAPK_2088
were in fact absent from the CAN6b PPDj preparation.
This may suggest that these CLPs are less important for
antigenic specificity compared to the other CLPs. Inter-
estingly the seven CLPs identified in PPDj appear to be
conserved in the Mycobacterium avium complex with
orthologs in M. bovis more divergent based on amino
acid sequence (Table 2). Specific CLPs have been shown
to elicit strong IFN-g responses, and when used as vac-
cine candidates, they conferred a moderate protection to
M. tuberculosis in a murine model [27]. Furthermore,
the IFN-g response was specific to individual CLPs and
demonstrated limited cross reactivity [27]. At least two
CLPs were also detected in PPDa in the study of Borsuk
et al. [16], however, these proteins were significantly
divergent to those identified in PPDj. MRM analysis
demonstrated that while CLPs are present in PPDa they
are significantly less abundant compared to most PPDj
preparations. Considering the diverse nature of CLPs
across the Mycobacterium genus, as well as their immu-
nogenic ability to elicit a strong IFN-g response, these
enzymes should be considered as possible diagnostic
antigens to replace PPDj.
Decreasing the inherent cross reactivity against non-
MAP mycobacterial antigens remains a significant chal-
lenge for improving JD diagnosis. In an attempt to identify
proteins which are unique to PPDj, we also characterised
the proteomic composition of PPD preparations produced
from Mycobacterium avium subsp. avium (PPDa) and
Mycobacterium bovis (PPDb). These PPD preparations are
commonly used as control antigens in IFN-g tests to con-
trol for antigenic cross reactivity against environmental
non-MAP mycobacteria. Interestingly, PPDa contained
significantly less proteins compared to PPDj and PPDb
(Figure 2). This finding is in agreement with a study by
Santema et al. [17] who demonstrated that the composi-
tion of PPDa was significantly less complex compared
with PPDj preparations. Nevertheless our study investi-
gated only one PPDa preparation and additional prepara-
tions should be examined to confirm this finding. Despite
fewer proteins, PPDa was highly similar in composition to
PPDj. Interestingly, many of the most common compo-
nents of PPDj were also identified in PPDa and PPDb
(Table 1). MRM analysis demonstrated that PPDa had
very similar abundance of the acyl carrier protein acpM
compared to PPDj (Figure 4B). Conserved proteins that
are shared between different mycobacterial PPD prepara-
tions undoubtedly increase the likelihood of cross reactiv-
ity. Two proteins that were found to be unique to PPDj
are the peroxiredoxin subunits C and D (ahpC and ahpD).
These proteins have been evaluated as potential diagnostic
antigens previously and have been shown to be specific to
MAP with little cross reactivity against other mycobacteria
[28,29]. A recent review by Mikkelsen et al. [30] suggests
ahpC and ahpD a r et w oo ft h em o s tp r o m i s i n ga n t i g e n s
for measuring specific cell mediated immunity. Other pro-
teins which were common in PPDj, but absent in PPDa
and PPDb include phosphoenolpyruvate carboxykinase
(pckA), malate dehydrogenase (mdh), the molecular
Figure 3 Five-way Venn diagram of protein composition
shared between the five in-house AAHL PPDj preparations.
Numbers within each segment represent the total number of
proteins shared by those preparations.
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Page 5 of 12Figure 4 MRM peptide quantification for lysozyme C control (A); MAPK_1771 acyl carrier protein (acpM) control (B); MAPK_0117 acyl-
CoA dehydrogenase FadE3_2 (C); MAV_1440 a glyoxalase/bleomycin resistance protein (D) and four cutinase like proteins (CLP)
MAPK_0273, MAPK_0340, MAPK_1748 and MAPK_2088 (E-H). The target peptide sequence is also presented in the top right-hand corner of
each plot.
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tase (eno). The immunogenicity of these proteins, how-
ever, remains to be evaluated.
In an attempt to identify the optimal harvest time
point for PPDj preparation temporal differences in pro-
tein secretion of in vitro cultured MAP (CLIJ623) was
examined. The number of secreted proteins identified in
the cell free culture filtrates increased with age from 72
individual proteins at 20 weeks to 97 proteins at 34
weeks (Additional file 2: Table S2). Interestingly, many
proteins identified in the cell-free culture filtrate did not
contain a signal peptide and were thus not expected to
be secreted. In fact 74% of proteins identified in the
cell-free culture filtrate had a signal peptide probability
of < 0.5. This finding suggests intracellular proteins are
frequently released following cell death and autolysis at
these time points. We hypothesised that the secretome
is comparable to PPDj, in that PPDj should contain all
secretome proteins, as well as some cellular proteins.
However, while many of the secreted proteins were also
found in PPDj, approximately 20% of these proteins
were not observed in PPDj. Furthermore, only 44 pro-
teins were secreted at both time points. This result sug-
gests that PPDj compositio nm a yv a r ys i g n i f i c a n t l y
depending on the age of the culture. Previously, we have
demonstrated that many of the major components of
PPDj, such as GroEL2 (hsp65), bacterioferritin and
ahpC,a r en o ts e c r e t e di nl a r g eq u a n t i t i e si nMycobac-
terium avium subsp. avium at either 7 or 14 weeks [31].
In our laboratory Mycobacterium avium subsp. avium
PPDa is produced from 13 week cultures and thus may
have vast quantitative differences in protein composition
compared to PPDj which is produced from 24 week
cultures.
Database interrogation revealed that some proteins
identified in PPDj had higher sequence coverage to
other Mycobacterium species compared to the MAP
K10 reference. This situation most likely stems from
either incorrectly annotated start open reading frames in
MAP K10 or simply that the open reading frame has
not been annotated onto the K10 genome at all. Our
study identified at least five cases of the latter (Addi-
tional file 3: Table S3). Homology searches on the K10
genome revealed six un-annotated open reading frames
corresponding to these five proteins. One of these pro-
teins was a glyoxalase/bleomycin resistance protein, clo-
sely resembling MAV_1440 in Mycobacterium avium
(strain 104). Interestingly, initial mass spectrometry ana-
lysis showed this protein to be unique to AAHL PPDj
preparations (Additional file 1: Table S1) however,
MRM analysis demonstrates that while it is generally
more abundant in AAHL PPDj samples, it could also be
detected in other PPDj and PPDa preparations (Figure
4D).
Conclusions
This study describes the production and proteomic
characterisation of PPDj within our laboratory. The pro-
teomic compositions of the PPDj preparations produced
in our laboratory are highly similar to PPDj preparations
produced in other institutes/laboratories in terms of
general composition. However, considerable differences
in absolute abundance of specific proteins were also
observed. Compositional differences between PPDj pre-
parations are to some extent a direct reflection of
genetic differences between the MAP strain types and
indirect temporal changes in growth stages and harvest
time point. We strongly advocate the use of a well char-
acterised MAP reference strain, with well described
growth dynamics, for all PPDj production globally.
Furthermore a standardised harvest time point at 24
weeks will reduce the influence of temporal changes in
protein expression thereby generating a more uniform
preparation. The immunogenic CLPs identified in across
the PPDj preparations should be further evaluated as
possible diagnostic targets.
Methods
MAP inoculum
All PPDs produced within our laboratory were derived
from an Australian wild type bovine MAP isolate
referred to as CLIJ623. This isolate was recovered from
Table 2 Similarity of amino acid sequence of cutinase-like proteins from MAP
Locus Tags Similarity to Mb
† Similarity to MAH
± Similarity to MAA
g
‡MAPK_0273/
¥MAP_3495c 50% to Mb3751 88% to MAV_2169 100% to MaviaA2_23256
‡MAPK_0340/
¥MAP_3428c 46% to Mb3482 99% to MAV_4283 99% to MaviaA2_18901
‡MAPK_1464/
¥MAP_2304 51% to Mb2006c 99% to MAV_1682 99% to MaviaA2_010100007523
‡MAPK_1748/
¥MAP_2020 55% to Mb1788 96% to MAV_2169 100% to MaviaA2_010100009430
‡MAPK_2088/
¥MAP_1680c 75% to Mb2006c 98% to MAV_2741 99% to MaviaA2_11201
‡MAPK_3435/
¥MAP_0333 78% to Mb3751 100% to MAV_0369 99% to MaviaA2_01656
‡MAPK_4239/
¥MAP_4237c 74% to Mb3481 99% to MAV_4394 99% to MaviaA2_010100019466
Compared to Mycobacterium bovis
†, Mycobacterium avium subsp. hominissuis
± and Mycobacterium avium subsp. avium
g. The closest ortholog locus tag is also
indicated. The MAP Locus tags from the revised K10 genome sequence
‡ and original K10 genome sequence
¥ are indicated
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symptoms of the terminal stages of Johne’sd i s e a s e .I t
was typed as a cattle (Type II) strain by a number of
tests: typical colony formation on Herrold’sE g gY o l k
medium (HEYM) supplemented with mycobactin and
sodium pyruvate [32-34], mycobactin dependency, char-
acteristic acid-fast microscopic morphology, PCR detec-
tion of the insertion element IS900 and restriction
enzyme analysis of IS1311 [23,35-39]. This isolate has
also recently undergone whole genome sequencing [4].
This virulent Australian wild-type strain, with minimal
laboratory passage (less than 3 passages), has been used
in long term infection time course experiments in cattle,
sheep and goats [23-25].
Preparation and source of PPD
Five batches of PPDj were produced between 2001 and
2007 within our laboratory. All five PPDj preparations
were produced identically using the same MAP strain
and preparation procedure and are considered biological
replicates. PPDj was prepared using a modified protocol
originally provided by CSL Limited. The mother seed of
CLIJ623 was first grown on HEYM slopes supplemented
with 2 mg/L of Mycobactin J (Allied Monitor Inc, Fay-
ette, USA). and sodium pyruvate for eight to twelve
weeks. HEYM slopes were prepared exactly as described
in the Australia and New Zealand Standard Diagnostic
Procedures (ANZSDPs) for Paratuberculosis http://www.
scahls.org.au/procedures/anzsdps. Approximately 10
8
bacilli per mL were then inoculated into modified Wat-
son and Reid media (media volume to flask volume 1/
10). The modified Watson and Reid media was prepared
as previously described by Morrison [40] and contained
2 mg/L of Mycobactin J (Allied Monitor Inc). The final
pH was adjusted to between 5.8-5.9 using NaOH.
Growth was monitored weekly during a stationary incu-
bation for 24 weeks after which time a thick dominant
pellicle was observed. At this point cultures were inacti-
vated in a steam autoclave at 100°C for 2 h and cooled
to 4°C overnight. Sterilised cultures were filtered
through sterile gauze and transferred into sterile centri-
fugation pots for centrifugation at 3,000 × g for 10 min.
The resultant supernatants were transferred to new pre-
weighed centrifuge pots and 40% (w/v) TCA solution in
distilled water was added to final concentration of 4%.
The mixture was stirred for at least 30 min with mag-
netic stirrer and placed (without stirring) in the dark
room at room temperature for 15-18 h. During this per-
iod the tuberculo-proteins were precipitated by the
TCA. Following precipitation the preparation was cen-
trifuged at 2,600 × g for 15 min. This step generated a
soft pellet that was often difficult to retain and a second
centrifugation step was sometimes required. Once the
pellet was well formed the supernatant was carefully
decanted and pellets retained. The resulting pellet was
washed with 5% NaCl (w/v) + 0.5% phenol (w/v)
(adjusted to pH 3.0 with 40% (w/v) TCA). Pots were
centrifuged at 2,600 × g for 15 min and washing was
repeated three times until the pH of the supernatant
was between 2 and 3, and the amount of wet-weight
was measured. The washed pellets were dissolved in
1.8% (w/v) Na2HPO4.2 H 2O (pH 11) with the amount
added equalling approximately 2-2.5 mL per gram of
wet-weight. Each protein pellet dissolved completely
within 90-120 min and the pH of the resultant prepara-
tion was 9.7. These preparations were centrifuged at
2,600 × g for 10 min and supernatants were mixed with
an equal volume of phosphate buffer (1.5% (w/v)
KH2PO4 + 3% (w/v) Na2HPO4.2 H 2O) containing 19.4%
(w/v) glucose and 0.5% (w/v) phenol. The pH of each
preparation was checked to be in the range of 6.7-6.9.
Concentrated PPDj preparations were stored at 4°C in
the dark. Additional PPD preparations were obtained
from various institutes/laboratories as outlines in Table
3. Total protein was quantified for each PPD using the
2-D Quant Kit (GE Healthcare) as per the manufac-
turer’s recommendation.
IFN-g assay
The in-house PPDj preparation, AAHL1101, was com-
pared to the PPDj preparations produced in Canadian
(CAN6) and CSL in its ability to stimulate the IFN-g
response in both Holstein-Friesian cattle and Merino
sheep experimentally infected with JD. Blood sample for
IFN-g testing were obtained from previous animal infec-
tion experiments described by Stewart et al [23,25].
Briefly, Holstein-Friesian calves (six weeks of age) or
Merino sheep (six months of age) were experimentally
infected at weekly intervals for four weeks with either 1
×1 0
10-2 × 10
10 cultured bacteria (bovine MAP strain)
or JD infected ileal and distal jejunal mucosal scaping.
Previous studies have demonstrated that infection is
more easily established with an infected mucosal inocu-
lum compared to a pure bacterial challenge [23-25]. The
control groups were dosed with Watson and Reid media
without mycobactin. For the purpose of comparing
PPDj preparations blood samples taken 45 months post
challenge were used. Neither cattle nor sheep demon-
strated clinical signs of disease (faecal shedding, loss of
body weight and diarrhoea) at this time point. However,
positive faecal culture - indicative of a subclinical infec-
tion - was observed for both infected cattle and sheep
previous to this time point [23,25].
The IFN-g assay was performed on duplicate plasma
samples with BOVIGAM™ kits following stimulation of
blood with either sterile phosphate-buffered saline (nil
antigen), Mycobacterium avium PPDa or one of three
PPDj samples. The IFN-g assay was performed exactly
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obtained from either Holstein-Friesian cattle or Merino
sheep experimentally infected with MAP (through either
tissue or bacterial inoculum) as described by Stewart et
al. [23,25]. The assays were performed on single plates
and the results are reported as optical densities. The
response of infected animals to AAHL1101, CSL or
CAN6 PPDj was compared using a One-way analysis of
variance (ANOVA).
Time course secretome
The composition of secreted MAP proteins within the
culture media was investigated at two independent time
points. Temporal differences in protein secretion of in
vitro cultured MAP may significant influence PPDj com-
position. The bovine strain CLIJ623 was cultured in
modified Watson and Reid (protein free) media as
described above. Culture media was harvested at 20 and
34 weeks post inoculation. Media was concentrated
using an Amicon filter membrane as previously
described [31]. Total protein was quantified for each
PPD using the 2-D Quant Kit (GE Healthcare) as per
the manufacturer’s recommendation. Fifty micrograms
of protein was then analysed by LC-MS/MS as described
below.
Trypsin digest
A total of 15 PPD and two secretome samples were ana-
lysed by mass spectrometry (Table 3). This included five
PPDj preparations prepared within our laboratory and
ten additional PPD samples obtained from other insti-
tutes/laboratories. These additional PPD preparations
were derived from Australia, Canada, The Netherlands,
Norway and the USA and were derived from Mycobac-
terium avium subsp. paratuberculosis (PPDj), Mycobac-
terium avium subsp. avium (PPDa) and Mycobacterium
bovis ( P P D b ) .T h eP P Dp r e p a r a t i o n s( 5 0μg) were first
subjected to reduction with 0.2 mM dithiothreitol
(DTT) in 40 mM NH4HCO3 for 2 h at 37°C, followed
by alkylation with 50 mM iodoacetamide for 20 mins in
the dark at room temperature. PPD proteins were then
digested overnight with 2.5 μg of trypsin (protein
sequencing grade; Sigma Aldrich) at 37°C. Digestion was
terminated by the addition of 0.8% (w/v) formic acid
and PPD digests were dried by vacuum centrifugation.
Chromatography
Protein digests were reconstituted in 0.1% formic acid
and 1 μg of tryptic peptides were chromatographically
resolved using a Shimadzu Prominence LC20 HPLC sys-
tem with a C18 Vydac column (75 μm × 15 cm, 300 Å,
5 μm). A linear gradient at flow rate of 800 nL/min
from 1-40% solvent B over 80 min was utilised where
solvent A was 0.1% (w/v) formic acid and solvent B was
0.1% (w/v) formic acid in 90% acetonitrile.
Mass Spectrometry
The eluate from the HPLC system was directly coupled
to the nanoelectrospray ionisation source of a Triple-
TOF™ 5600 system (AB/Sciex, Foster City, CA, USA).
Data were acquired in information dependent acquisi-
tion (IDA) mode. The IDA method consisted of a high
resolution TOF-MS survey scan followed by 20 MS/MS
in a second with a maximum accumulation time of 50
ms. First stage MS analysis was performed in positive
ion mode over the mass range m/z 300-2000 with a 0.5
Table 3 List of 15 PPD samples analysed in this study
PPD Species Lot Country Provider
AAHL1101 MAP NA Australia NA
AAHL0604 MAP NA Australia NA
AAHL0106 MAP NA Australia NA
AAHL0906 MAP NA Australia NA
AAHL0507 MAP NA Australia NA
CSL MAP 0404-21601 Australia CSL Limited
CAN 6 MAP 0404-41101:8 Canada CSL Limited
CAN 6a MAP 90-00-1:68 Canada CSL Limited
CAN 6b MAP 90-00A Canada Canadian Food Inspection Agency
CAN 6+ MAP 0404-41101:8 Canada CSL Limited
DPF MAP 0404-41101:8 The Netherlands Pfizer Animal Health
NVI MAP NA Norway National Veterinary Institute
NVSL MAP 9801 USA National Veterinary Service Laboratory (USDA)
PPDa MAA 2091-02301 Australia CSL Limited
PPDb Mb 209000901 Australia CSL Limited
All PPD samples prefixed with AAHL were produced in-house. The NVSL PPDj was excluded from further analysis due to an unexpectedly low number of
identified proteins. For species the abbreviation MAP = Mycobacterium avium subsp paratuberculosis,M A A=Mycobacterium avium subsp. avium, and Mb =
Mycobacterium bovis.
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2600 V, the curtain gas was set to 25, the nebuliser gas
to 20 and the heated interface was set to 150°C. Tandem
mass spectra were acquired over the mass range m/z
100-2000 using rolling collision energy (CE) for opti-
mum peptide fragmentation. Precursor ion masses were
excluded for 8 s after two occurrences.
Database searching and false discovery rate analysis
All data were processed using ProteinPilot v4.0 with
integrated false discovery rate analysis. The spectral sets
were searched against all Mycobacteriaceae proteins pre-
sent in the Uniprot database (version 20110721; 430,740
proteins). Search parameters were defined as cysteine
alkylation with iodoacetamide, trypsin as the digestion
enzyme and no restrictions were placed on taxonomy.
Modifications were set to the “generic workup” and
“biological” modification sets provided with this software
package, which consisted of all modifications listed in
Unimod, for example, acetylation, methylation and
phosphorylation. The generic workup modifications set
contains 59 potential modifications that may occur as a
result of sample handling, for example, oxidation, dehy-
dration and deamidation. The identification of proteins
was recorded in the Results section if MS/MS spectral
scores were achieved at the p < 0.01 confidence level, i.
e. at a 1% global false discovery rate (FDR). Only pro-
teins for which two peptides were identified were con-
sidered to be present. Signal peptide probability was
determined using SignalP 3.0 [41].
Multiple reaction monitoring (MRM)
Quantification of individual proteins was compared
between PPDj and PPDa preparations based on MRM
mass spectrometry analysis. A total of 50 μg of lysozyme
C (Sigma-Aldrich) was trypsin digested as described
above. Each PPDj and PPDa sample was then spiked
with 0.05 μg of digested lysozyme C and analysed on a
4000 QTRAP mass spectrometer (Applied Biosystems,
Framingham, MA, USA) equipped with a TurboV ioni-
zation source operated in positive ion mode. Samples
were chromatographically separated on a Shimadzu Pro-
minence LC20 HPLC system with a C18 Vydac column
(75 μm × 15 cm, 300 Å, 5 μm). A linear gradient at
flowrate of 800 nL/min from 1-40% solvent B over 20
min was utilised where solvent A was 0.1% formic acid
and solvent B was 0.1% (w/v) formic acid in 90% aceto-
nitrile. The eluent from the HPLC was directly coupled
to the mass spectrometer. Data were acquired and pro-
cessed using Analyst 1.5 software™ Quantification of
MAP peptides was achieved using scheduled MRM
scanning experiments using a 120 s detection window
for each MRM transition and a 1 s cycle time. A total of
seven target proteins were quantified including four
cutinase-like proteins (Locus tags; MAPK_0340,
MAPK_0273, MAPK_1748 and MAPK_2088), the acyl-
CoA dehydrogenase FadE3_2 (MAPK_0117), a glyoxa-
lase/bleomycin resistance protein (MAV_1440) and the
acyl carrier protein acpM (MAPK_1771). For each pro-
tein a single peptide was chosen for quantification using
the summed area of the two most intense MRM transi-
tions. MRM peak areas were normalised using the
MRM peak area of the positive control peptides from
lysozyme C (Figure 4A).
Additional material
Additional file 1: Table S1. Proteins identified in each PPD are
indicated by +. UniProt accession number for the protein with highest
sequence coverage is given. K10 locus tag (revised version [26] and
original version [42]), gene name, mass (Da) and protein name for the
MAP K10 ortholog is provided. Ortholog locus tags for proteins identified
in PPDa and PPDb which were also found in PPDj are provided.
Additional file 2: Table S2. Proteins identified in culture filtrate at 20
and 34 weeks post inoculation are indicated by +. UniProt accession
number for the protein with highest sequence coverage is given. K10
locus tag (revised version [26] and original version [42]), gene name,
mass (Da) and protein name for the MAP K10 ortholog is provided.
Proteins that were also identified in one or more PPDj are indicated by
+. Signal peptide probability was calculated by SignalP 3.0.
Additional file 3: Table S3. Description of non-annotated proteins
identified in PPDj. The identified M. avium 104 ortholog locus tag is
provided, along with genome coordinated where the open reading
frames are positioned in the K10 genome.
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